Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Neurological pathways via pressure point stimulation does not refer to a single molecule or receptor, but instead describes the complex neural circuits activated by physical stimulation of specific anatomical sites known as acupoints or trigger points, commonly used in acupuncture and acupressure. These stimulations are thought to activate dense clusters of peripheral nerve endings—primarily A-delta and C fibers—which then transmit signals through spinal cord tracts into various brain regions involved in pain perception/modulation (such as the hypothalamus, thalamus), emotional processing centers (limbic system), autonomic control nuclei (nucleus tractus solitarius [NTS], paraventricular nucleus [PVN]), reward circuitry (nucleus accumbens), motor control areas relevant for movement disorders like Parkinson’s disease, among others. Functional MRI studies show that both acupuncture needle insertion and deep pressure at these points can modulate activity across multiple CNS structures—often activating antinociceptive descending systems while deactivating limbic areas associated with pain affect. The precise pattern depends on both the location stimulated (“acupoint specificity”) and method used. There is also evidence that these interventions can influence autonomic outputs such as heart rate variability, blood pressure, stress responses, mood states, etc. Because this term refers broadly to physiological networks rather than discrete drug targets, it should not be classified alongside canonical therapeutic targets like receptors or enzymes. It is best described functionally—as an ensemble of neuroanatomic connections mediating systemic effects from localized somatic input. In summary: "Neurological pathways via pressure point stimulation" is not a canonical molecular target but refers collectively to interconnected neural circuits activated by mechanical/acupuncture stimuli at defined body locations. These networks mediate diverse physiological responses—including analgesia, autonomic regulation, emotional modulation—but do not correspond to any single protein/receptor/enzymes suitable for direct pharmacologic targeting.
Not applicable for drugs; however, pressure point stimulation is believed to: Activate peripheral nerves at acupoints, especially A-delta and C fibers; Modulate central nervous system activity in regions such as the hypothalamus, thalamus, limbic system, nucleus accumbens, anterior cingulate cortex, and motor cortex through ascending and descending neural pathways; Influence neurotransmitter release including endorphins/opioids in the brainstem and spinal cord.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Neurological pathways via pressure point stimulation (None).